Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252

Edith A. Perez, Vera J. Suman, Kendrith M. Rowland, James N. Ingle, Muhammad Salim, Charles L. Loprinzi, Patrick J. Flynn, James A. Mailliard, Carl G. Kardinal, James E. Krook,

Clinical Breast Cancer · 2005 · 137 citations · 26 references

Concepts

References

26